Lenvatinib under the microscope: safety check for tough thyroid cancers
Disease control
Completed
This study looked at the safety of the drug lenvatinib in 50 people with advanced thyroid cancer that had stopped responding to radioactive iodine treatment. Researchers tracked side effects and how often patients needed to lower their dose. They also checked whether tumors shran…
Phase: PHASE4 • Sponsor: Eisai Pharmaceuticals India Pvt. Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC